Spruce Biosciences, Inc. Accumulated Other Comprehensive Income
Spruce Biosciences, Inc. (SPRB) had Accumulated Other Comprehensive Income of $0 as of 2023-12-31, per its 10-K filed 2024-03-18.
Discontinued › Balance Sheet › Equity
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-03-18
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.00K.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$55.00K.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$188.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-18 |
| 2023-09-30 | -$3.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$55.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$188.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$558.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | -$873.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$845.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$693.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$184.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | -$16.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$29.00K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |